TABLE 1B 2005 COMMUNITY PRESCRIPTION NUMBERS, TOGETHER WITH GOVERNMENT AND PATIENT COSTS FOR PBS-LISTED DRUGS Table 1B includes an estimate of community (non-public hospital) prescription numbers for the 2005 calendar year, costs (government and patient contribution) for the items with a four digit PBS/RPBS code, together with the defined daily dose (DDD) where assigned. There is no cost information available for items with a five digit Amfac drug code. Table 1 exclude the presentation of information on any item with an estimated community use of less than 110 prescriptions in 2005. The prescription items are arranged by ATC code on generic name, and by form and strength using either the PBS drug code (4 digit) or, for non-PBS items, the Amfac drug code (5 digit). Consult the index (page 255) by generic drug name to obtain the appropriate ATC code. An index by 2nd level of the ATC classification follows: ALIMENTARY TRACT AND METABOLISM PAGE NO A01 STOMATOLOGICAL PREPARATIONS 181 A02 DRUGS FOR ACID RELATED DISORDERS 182 A03 DRUGS FOR FUNCTIONAL GASTROINTESTINAL DISORDERS 185 A04 ANTIEMETICS AND ANTINAUSEANTS 187 A05 BILE AND LIVER THERAPY 188 A06 LAXATIVES 189 A07 ANTIDIARRHOEALS, INTESTINAL 191 ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS A08 ANTIOBESITY PREPARATIONS, EXCLUDING DIET PRODUCTS 193 A09 DIGESTIVES, INCLUDING ENZYMES 194 A10 DRUGS USED IN DIABETES 195 A11 VITAMINS 197 A12 MINERAL SUPPLEMENTS 199 A14 ANABOLIC AGENTS FOR SYSTEMIC USE 200 177 BLOOD AND BLOOD FORMING ORGANS B01 ANTITHROMBOTIC AGENTS 201 B02 ANTIHAEMORRHAGICS 203 B03 ANTIANAEMIC PREPARATIONS 204 B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS 205 B06 OTHER HAEMATOLOGICAL AGENTS 206 CARDIOVASCULAR SYSTEM C01 CARDIAC THERAPY 207 C02 ANTIHYPERTENSIVES 209 C03 DIURETICS 210 C04 PERIPHERAL VASODILATORS 211 C05 VASOPROTECTIVES 212 C07 BETA BLOCKING AGENTS 213 C08 CALCIUM CHANNEL BLOCKERS 214 C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM 215 C10 SERUM LIPID REDUCING AGENTS 217 DERMATOLOGICALS D01 ANTIFUNGALS FOR DERMATOLOGICAL USE 218 D02 EMOLLIENTS AND PROTECTIVES 220 D03 PREPARATIONS FOR TREATMENT OF WOUNDS AND ULCERS 221 D04 ANTIPRURITICS, INCLUDING ANTIHISTAMINES, ANAESTHETICS ETC 222 D05 ANTIPSORIATICS 223 D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE 224 D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS 225 D08 ANTISEPTICS AND DISINFECTANTS 227 D09 MEDICATED DRESSINGS 228 D10 ANTI-ACNE PREPARATIONS 229 D11 OTHER DERMATOLOGICAL PREPARATIONS 230 GENITOURINARY SYSTEM AND SEX HORMONES G01 GYNAECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS 231 G02 OTHER GYNAECOLOGICALS 232 G03 SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM 233 G04 UROLOGICALS 238 178 SYSTEMIC HORMONAL PREpaRATIONS, EXCL. SEX HORMONES AND INSULINS H01 PITUITARY AND HYPOTHALAMIC HORMONES AND ANALOGUES 239 H02 CORTICOSTEROIDS FOR SYSTEMIC USE 240 H03 THYROID THERAPY 241 H04 PANCREATIC HORMONES 241 H05 CALCIUM HOMEOSTASIS 241 GENERAL ANTIINFECTIVES FOR SYSTEMIC USE J01 ANTIBACTERIALS FOR SYSTEMIC USE 242 J02 ANTIMYCOTICS FOR SYSTEMIC USE 249 J04 ANTIMYCOBACTERIALS 250 J05 ANTIVIRALS FOR SYSTEMIC USE 251 J07 VACCINES 252 ANTINEOPLASTIC AND IMMUNO-MODULATING AGENTS L01 ANTINEOPLASTIC AGENTS 254 L02 ENDOCRINE THERAPY 260 L03 IMMUNOSTIMULANTS 261 L04 IMMUNOSUPPRESSIVE AGENTS 262 MUSCULO-SKELETAL SYSTEM M01 ANTI-INFLAMMATORY AND ANTI-RHEUMATIC PRODUCTS 263 M02 TOPICAL PRODUCTS FOR JOINT AND MUSCULAR PAIN 266 M03 MUSCLE RELAXANTS 267 M04 ANTIGOUT PREPARATIONS 268 M05 DRUGS FOR TREATMENT OF BONE DISEASES 269 NERVOUS SYSTEM N01 ANAESTHETICS 270 N02 ANALGESICS 271 N03 ANTIEPILEPTICS 278 N04 ANTI-PARKINSON DRUGS 281 N05 PSYCHOLEPTICS 283 N06 PSYCHOANALEPTICS 288 N07 OTHER NERVOUS SYSTEM DRUGS 292 ANTIpaRASITIC PRODUCTS, INSECTICIDES AND REPELLENTS P01 ANTIPROTOZOALS 293 P02 ANTHELMINTICS 294 P03 ECTOPARASITICIDES, INCLUDING SCABICIDES, INSECTICIDES AND REPELLENTS 295 179 RESPIRATORY SYSTEM R01 NASAL PREPARATIONS 296 R03 DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES 298 R05 COUGH AND COLD PREPARATIONS 301 R06 ANTIHISTAMINES FOR SYSTEMIC USE 302 SENSORY ORGANS S01 OPHTHALMOLOGICALS 305 S02 OTOLOGICALS 310 S03 OPHTHALMOLOGICAL AND OTOLOGICAL PREPARATIONS 311 VaRIOUS V01 ALLERGENS 312 V03 ALL OTHER THERAPEUTIC PRODUCTS 313 180 A 2005 ATC CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($) ALIMENTARY TRACT AND METABOLISM STOMATOLOGICAL PREPARATIONS STOMATOLOGICAL PREPARATIONS ANTIINFECTIVES FOR LOCAL ORAL TREATMENT A01AB04 AMPHOTERICIN 2931 Lozenge 10 mg 40.00 MG 148,722 1,276,858 3306 Lozenge 10 mg 40.00 MG 4,458 37,489 A01AB03 CHLORHEXIDINE 4160 Mouth wash 2 mg per ml (0.2%), 250 ml 30.00 MG 111 1,282 4161 Mouth wash 2 mg per ml (0.2%), 250 ml 30.00 MG 3,205 34,604 A01AB09 MICONAZOLE 13832 Oral gel 20 mg per ml (2%), 20 g 0.20 GM 12,443 – 14054 Oral gel 40 mg per ml (2%), 40 g 0.20 GM 6,003 – A01AB11 NYSTATIN 3033 Oral suspension 100,000 units per ml, 24 ml 1500.00 TE 147,209 1,366,099 3343 Oral suspension 100,000 units per ml, 24 ml 1500.00 TE 1,138 10,386 16261 Pastille 100,000 units 28 – – 653 – A01AB11 POVIDINE IODINE 10359 Gargle 1 – – 197 – A01AB11 THYMOL 11202 Mouth wash red 200ml – – 97 – CORTICOSTEROIDS FOR LOCAL ORAL TREATMENT A01AC01 TRIAMCINOLONE ACETONIDE with PECTIN 11075 Paste 1% 5gm – – 32,081 – OTHER AGENTS FOR LOCAL ORAL TREATMENT A01AD02 BENZYDAMINE HYDROCHLORIDE 1121 Mouth and throat rinse 22.5mg per 15mL,500mL – – 6,720 120,239 5032 Mouth and throat rinse 22.5mg per 15mL – – 59 1,087 13467 Gel 3% 30g 1 – – 232 – 13655 Gel 5% 30g 1 – – 298 – 13757 Gel 3% 75g 1 – – 608 – 14683 Solution 0.15% 200 ml – – 189 – A01AD02 BENZYDAMINE with CHLORHEXIDINE 14358 Solution 100 ml – – 256 – 14359 Solution 200mL – – 49 – A01AD11 CHOLINE SALICYLATE with CETALKONIUM CHLORIDE 12855 Gel 10g 1 – – 3,872 – A01AD11 SALIVA SUBSTITUTE 4568 Solution 25 ml – – 312 2,586 4569 Solution 100 ml – – 665 9,107 A01AD11 VARIOUS 5334 Spray 10mg per mL, 100 mL – – 236 2,543 181 A 2005 ATC CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($) ALIMENTARY TRACT AND METABOLISM DRUGS FOR ACID RELATED DISORDERS ANTACIDS ALUMINIUM COMPOUNDS A02AB01 ALUMINIUM HYDROXIDE 10038 Tablet 600 mg 100 – – 786 – CALCIUM COMPOUNDS A02AC10 CALCIUM CARBONATE with GLYCINE 4055 Tablet 420 mg-180 mg – – 566 10,776 COMBS AND COMPLEXES OF ALUMINIUM,CALCIUM AND MAGNESIUM COMPOUNDS A02AD ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE 2157 Oral suspension 200 mg-200 mg per 5 ml, 500 ml – – 59,444 746,589 2576 Tablet 200 mg-200 mg – – 49,358 614,705 4117 Tablet 400 mg-400 mg-30 mg – – 3,478 82,381 4118 Oral suspension 400 mg-400 mg-30 mg per 5 ml, – – 1,970 36,289 A02AD ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE with SIMETHICONE 11195 Table (chewable) 50 – – 122 – 11196 Mixture 750ml 1 – – 138 – A02AD ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE with SIMETHICONE with SORBITOL 11225 Table (chewable) 50 – – 158 – A02AD ALUMINIUM HYDROXIDE with MAGNESIUM TRISILICATE and MAGNESIUM HYDROXIDE 2159 Oral suspension 250 mg-120 mg-120 mg per 5 ml, – – 39,841 497,156 18762 Tablet 250 mg-120 mg-120 mg – – 243 – ANTACIDS, OTHER COMBINATIONS A02AX ALUMINIUM HYDROXIDE with MAGNESIUM HYDROXIDE with OXETHAZAINE 16009 Mixture 500ml 1 – – 875 – DRUGS FOR PEPTIC ULCER AND GORD H2-RECEPTOR ANTAGONISTS A02BA01 CIMETIDINE 1156 Effervescent tablet 800 mg (as hydrochloride) 0.80 GM 2,715 74,834 1157 Tablet 200 mg 0.80 GM 4,431 119,472 1158 Tablet 400 mg 0.80 GM 40,119 1,093,524 1159 Tablet 800 mg 0.80 GM 6,495 181,385 8901 Effervescent tablet 800 mg (as hydrochloride) 0.80 GM 271 11,748 A02BA03 FAMOTIDINE 2487 Tablet 20 mg 40.00 MG 112,016 2,388,087 2488 Tablet 40 mg 40.00 MG 101,509 2,299,267 A02BA04 NIZATIDINE 1504 Capsules 300mg 30 0.30 GM 25,810 614,262 1505 Capsules 150mg 30 0.30 GM 84,097 1,913,414 4967 Capsules 150mg 60 0.30 GM 174 4,476 4969 Capsules 300mg 30 0.30 GM 64 2,370 8931 Capsules 150mg 60 0.30 GM 970 25,235 8933 Capsules 300mg 30 0.30 GM 300 11,045 A02BA02 RANITIDINE HYDROCHLORIDE 1937 Effervescent tablet 150 mg (base) 0.30 GM 55,434 1,215,991 1977 Tablet 300 mg (base) 0.30 GM 313,986 7,095,599 1978 Tablet 150 mg (base) 0.30 GM 1,119,067 24,541,469 4978 Effervescent tablet 150 mg (base) 0.30 GM 500 12,472 4980 Syrup 150 mg (base) per 10 ml, 300 ml 0.30 GM 709 17,173 8162 Syrup 150 mg (base) per 10 ml, 300 ml 0.30 GM 18,742 370,539 8903 Effervescent tablet 150 mg (base) 0.30 GM 1,463 37,492 8905 Syrup 150 mg (base) per 10 ml, 300 ml 0.30 GM 443 13,653 17164 Tablet 150 mg 14 0.30 GM 316 – 182 A 2005 ATC CODE FORM AND STRENGTH DDD UNITS SCRIPTS COST($) ALIMENTARY TRACT AND METABOLISM DRUGS FOR ACID RELATED DISORDERS DRUGS FOR PEPTIC ULCER AND GORD PROSTAGLANDINS A02BB01 MISOPROSTOL 1648 Tablet 200 ug 0.80 MG 2,665 137,892 PROTON PUMP INHIBITORS A02BC05 ESOMEPRAZOLE 8600 Tablet 20 mg (enteric coated),30 30.00 MG 2,067,514 95,698,661 8601 Tablet 40 mg (enteric coated),30 30.00 MG 1,294,189 97,535,964 A02BC03 LANSOPRAZOLE 2240 Capsule 30 mg 30.00 MG 37,445 1,732,847 2241 Capsule 30 mg 30.00 MG 818,805 40,470,231 8198 Capsule 15 mg 30.00 MG 22,099 645,393 8528 Sachet for oral suspension, 30mg 30.00 MG 3,448 147,962 8529 Sachet for oral suspension, 30mg 30.00 MG 16,763 751,065 A02BC01 OMEPRAZOLE 1326 Capsule 20 mg 20.00 MG 20,675 801,170 1327 Capsule 20 mg 20.00 MG 203,625 9,613,825 8331 Tablet 20mg (base) 30 20.00 MG 149,101 6,437,686 8332 Tablet 10 mg 30 20.00 MG 57,017 1,697,342 8333 Tablet 20 mg 30 20.00 MG 3,866,360 183,135,279 8776 Tablet 20 mg 30 20.00 MG 2,447 105,012 8777 Tablet 20 mg 30 20.00 MG 23,458 1,070,636 15213 Vial 40 mg 10 ml 5 20.00 MG 483 – A02BC02 PANTOPRAZOLE 8007 Tablet (enteric coated) equivalent to 40mg 40.00 MG 258,470 12,102,901 8008 Tablet